共 50 条
- [21] STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusionJournal of Hematology & Oncology, 8Vivek SubbiahCaitlin McMahonShreyaskumar PatelRalph ZinnerElvio G SilvaJulia A. ElvinIshwaria M. SubbiahChimela OhajiDhakshina Moorthy GaneshanDeepa AnandCharles F. LevenbackJenny BerryTim BrennanJuliann ChmieleckiZachary R. ChalmersJohn MayfieldVincent A. MillerPhilip J. StephensJeffrey S. RossSiraj M. Ali
- [22] STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusionJOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8Subbiah, VivekMcMahon, CaitlinPatel, ShreyaskumarZinner, RalphSilva, Elvio G.Elvin, Julia A.Subbiah, Ishwaria M.Ohaji, ChimelaGaneshan, Dhakshina MoorthyAnand, DeepaLevenback, Charles F.Berry, JennyBrennan, TimChmielecki, JuliannChalmers, Zachary R.Mayfield, JohnMiller, Vincent A.Stephens, Philip J.Ross, Jeffrey S.Ali, Siraj M.
- [23] Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinibGYNECOLOGIC ONCOLOGY REPORTS, 2022, 43Carballo, Erica V.Pham, Tra V.Turashvili, GulisaHanley, KrisztinaStarbuck, Kristen D.Meisel, Jane L.
- [24] Fusion of Dynactin 1 (DCTN1) to ALK in Inflammatory Myofibroblastic TumorLABORATORY INVESTIGATION, 2011, 91 : 22A - 23AWang, X.Krishnan, C.Nguyen, E.Mayer, K. J.Oliveira, J. L.Yi, J. E.Yang, P.Yaszemski, M. J.Maran, A.Erickson-Johnson, M. R.Oliveira, A. M.
- [25] Fusion of Dynactin 1 (DCTN1) to ALK in Inflammatory Myofibroblastic TumorMODERN PATHOLOGY, 2011, 24 : 22A - 23AWang, X.Krishnan, C.Nguyen, E.Mayer, K. J.Oliveira, J. L.Yi, J. E.Yang, P.Yaszemski, M. J.Maran, A.Erickson-Johnson, M. R.Oliveira, A. M.
- [26] A Novel CASC15-ALK and TFG-ROS1 Fusion Observed in Uterine Inflammatory Myofibroblastic TumorINTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (05) : 451 - 459Chang, BinWang, ZheRen, MinYao, QianlanZhao, LuZhou, Xiaoyan
- [27] FN1: A Novel Fusion Partner of ALK in an Inflammatory Myofibroblastic TumorPEDIATRIC BLOOD & CANCER, 2015, 62 (05) : 909 - 911Ouchi, KazutakaMiyachi, MitsuruTsuma, YusukeTsuchiya, KunihikoIehara, TomokoKonishi, EiichiYanagisawa, AkioHosoi, Hajime
- [28] Inflammatory Myofibroblastic Tumor Driven by Novel NUMA1-ALK Fusion Responds to ALK InhibitionJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (02): : 115 - 121Rao, NishaIwenofu, HansTang, BingfengWoyach, JenniferLiebner, David A.
- [29] Uterine inflammatory myofibroblastic tumor with THBS1-INSR fusionPATHOLOGY RESEARCH AND PRACTICE, 2023, 246Sim, AngelaDevouassoux-Shisheboran, MojganBenmousaly-Rigollot, CameliaPicot, TiphaniePeoc'h, MichelKarpathiou, Georgia
- [30] A case of an inflammatory myofibroblastic tumor in the lung which expressed TPM3-ALK gene fusionPEDIATRIC SURGERY INTERNATIONAL, 2007, 23 (06) : 595 - 599Kinoshita, Y.Tajiri, T.Ieiri, S.Nagata, K.Taguchi, T.Suita, S.Yamazaki, K.Yoshino, I.Maehara, Y.Kohashi, K.Yamamoto, H.Oda, Y.Tsuneyoshi, M.